Cost Savings of Waste on Health by Pharmacological Inefficiencies in a Value-Based Patient Drug Safety Program
Author(s)
Madrigal Cadavid J1, Tabares JE2, Caro MA2, Rendon A2, Hincapie AM2, Abad JM3, Molina F3, Estrada Acevedo JI2, Giraldo PA2
1Helpharma, Medellin, ANT, Colombia, 2Helpharma, Medellin, Colombia, 3SURA EPS, Medellin, Colombia
OBJECTIVES: To describe the cost savings generated through the systematic identification of pharmacological inefficiencies in a value-based patient drug safety program of a Colombian pharmaceutical benefit manager.
METHODS: Descriptive observational study, conducted between May 2021 – May 2022, in patients diagnosed with high-cost chronic pathologies. The pharmacists systematically identified and resolved the potential inefficiencies associated with the medication. A univariate analysis was performed, with summary measures of central tendency and relative and cumulative frequencies. R Core Team statistical package (2019) was used. Further, the potential savings of wasteful spending health was calculated.
RESULTS: 11947patients were evaluated with a mean age of 57 years (SD:22), 63.0% were women, and 12894 inefficiencies associated with inappropriate medication use were identified and intervened. 51.4% corresponded to therapeutic duplications, 21.6% unneeded medication, 14.2% incorrect medication, 4.0% chronification of treatment, 3.7% over dosage, and 2.6% prescribing cascade. The acceptance rate of pharmaceutical management was 18%. The potential savings from pharmacist interventions were 1167949.63USD (97329.14 USD an average month).
CONCLUSIONS: The value-based patient drug safety program allows for the systematic identification and management of pharmacological inefficiencies, generating an impact on clinical and economic results. However, articulation between pharmacist-physician-insurer health is required to improve the effectiveness of the pharmacist intervention.
Conference/Value in Health Info
Value in Health, Volume 25, Issue 12S (December 2022)
Code
HSD69
Disease
No Additional Disease & Conditions/Specialized Treatment Areas